Submitted URL: https://dougallgpt.com/short/nl-external?dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventI...
Effective URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell...
Submission: On August 21 via api from BE — Scanned from DE

Summary

This website contacted 18 IPs in 3 countries across 12 domains to perform 87 HTTP transactions. The main IP is 2606:4700::6812:bac, located in United States and belongs to CLOUDFLARENET, US. The main domain is dougallmd.com.
TLS certificate: Issued by WE1 on July 1st 2024. Valid for: 3 months.
This is the only time dougallmd.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
2 12 2606:4700::68... 13335 (CLOUDFLAR...)
2 2 2600:9000:211... 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
2 2.17.100.131 20940 (AKAMAI-ASN1)
4 2620:1ec:bdf::67 8075 (MICROSOFT...)
4 2602:816:5001... 54113 (FASTLY)
7 20.114.189.70 8075 (MICROSOFT...)
3 2606:4700::68... 13335 (CLOUDFLAR...)
2 185.221.87.23 54113 (FASTLY)
2 18 2606:4700::68... 13335 (CLOUDFLAR...)
3 2a00:1450:400... 15169 (GOOGLE)
2 19 2606:4700::68... 13335 (CLOUDFLAR...)
2 185.221.85.3 206998 (NEW-2)
2 34.206.159.125 14618 (AMAZON-AES)
1 3.161.82.20 16509 (AMAZON-02)
2 2600:9000:211... 16509 (AMAZON-02)
2 2600:9000:276... 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
87 18
Apex Domain
Subdomains
Transfer
37 dougallmd.com
dougallmd.com
a.dougallmd.com
phnx.dougallmd.com
c-phnx.dougallmd.com
c-neml.dougallmd.com
p-dgan.dougallmd.com
3 MB
15 dougallgpt.com
dougallgpt.com — Cisco Umbrella Rank: 714260
a.dougallgpt.com
phnx.dougallgpt.com
c-phnx.dougallgpt.com
c-neml.dougallgpt.com
3 MB
11 clarity.ms
www.clarity.ms — Cisco Umbrella Rank: 1114
t.clarity.ms — Cisco Umbrella Rank: 8415
57 KB
6 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 110
5 KB
4 nr-data.net
bam.eu01.nr-data.net — Cisco Umbrella Rank: 11782
2 KB
4 newrelic.com
js-agent.newrelic.com — Cisco Umbrella Rank: 1453
103 KB
4 phnxml.io
api.phnxml.io — Cisco Umbrella Rank: 663893
5 KB
3 peerview.com
c.peerview.com
peerview.com — Cisco Umbrella Rank: 601920
271 KB
3 gstatic.com
fonts.gstatic.com
114 KB
2 imperium.com
rvid.imperium.com — Cisco Umbrella Rank: 94587 Failed
2 KB
2 aimatch.com
content.aimatch.com — Cisco Umbrella Rank: 125163
5 KB
1 neml.io
api.neml.io
828 B
87 12
Domain Requested by
17 phnx.dougallmd.com dougallmd.com
7 dougallmd.com 2 redirects dougallgpt.com
dougallmd.com
7 t.clarity.ms www.clarity.ms
dougallgpt.com
dougallmd.com
7 dougallgpt.com 2 redirects dougallgpt.com
6 c-phnx.dougallmd.com dougallmd.com
6 fonts.googleapis.com dougallgpt.com
dougallmd.com
4 a.dougallmd.com dougallmd.com
a.dougallmd.com
4 bam.eu01.nr-data.net dougallgpt.com
dougallmd.com
4 js-agent.newrelic.com dougallgpt.com
dougallmd.com
4 www.clarity.ms dougallgpt.com
dougallmd.com
4 api.phnxml.io 2 redirects
3 fonts.gstatic.com fonts.googleapis.com
3 c-phnx.dougallgpt.com dougallgpt.com
2 c.peerview.com
2 p-dgan.dougallmd.com 2 redirects
2 rvid.imperium.com dougallgpt.com
dougallmd.com
2 phnx.dougallgpt.com dougallgpt.com
2 a.dougallgpt.com dougallgpt.com
a.dougallgpt.com
2 content.aimatch.com dougallgpt.com
dougallmd.com
1 peerview.com
1 api.neml.io dougallmd.com
1 c-neml.dougallmd.com dougallmd.com
1 c-neml.dougallgpt.com dougallgpt.com
87 23

This site contains no links.

Subject Issuer Validity Valid
dougallgpt.com
WE1
2024-07-29 -
2024-10-27
3 months crt.sh
upload.video.google.com
WR2
2024-07-30 -
2024-10-22
3 months crt.sh
content.aimatch.com
E5
2024-07-13 -
2024-10-11
3 months crt.sh
www.clarity.ms
DigiCert TLS RSA SHA256 2020 CA1
2023-12-07 -
2024-12-07
a year crt.sh
js-agent.newrelic.com
GlobalSign Atlas R3 DV TLS CA 2024 Q1
2024-03-21 -
2025-04-22
a year crt.sh
a.clarity.ms
Microsoft Azure RSA TLS Issuing CA 08
2024-06-23 -
2025-06-18
a year crt.sh
a.dougallgpt.com
WE1
2024-07-21 -
2024-10-19
3 months crt.sh
phnx.dougallgpt.com
WE1
2024-08-16 -
2024-11-14
3 months crt.sh
c-phnx.dougallgpt.com
WE1
2024-08-07 -
2024-11-05
3 months crt.sh
*.eu01.nr-data.net
DigiCert TLS RSA SHA256 2020 CA1
2024-07-12 -
2025-07-11
a year crt.sh
c-neml.dougallgpt.com
WE1
2024-08-06 -
2024-11-04
3 months crt.sh
dougallmd.com
WE1
2024-07-01 -
2024-09-29
3 months crt.sh
*.gstatic.com
WR2
2024-07-30 -
2024-10-22
3 months crt.sh
*.imperium.com
Amazon RSA 2048 M02
2023-12-24 -
2025-01-21
a year crt.sh
api.neml.io
Amazon RSA 2048 M02
2024-01-29 -
2025-02-26
a year crt.sh
c.peerview.com
Amazon RSA 2048 M02
2024-02-21 -
2025-03-22
a year crt.sh
peerview.com
E6
2024-08-19 -
2024-11-17
3 months crt.sh

This page contains 1 frames:

Primary Page: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Frame ID: CD9B0809612BB07F88E530AB80B17DE9
Requests: 76 HTTP requests in this frame

Screenshot

Page Title

Dougall MD | Eftilagimod Improves Efficacy of Pembrolizumab in First-Line Treatment of Non-Small-Cell Lung Cancer

Page URL History Show full URLs

  1. https://dougallgpt.com/short/nl-external?dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougall... HTTP 302
    https://dougallgpt.com/short/nl-external?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1On... HTTP 301
    https://api.phnxml.io/v2/nl/urlresolver?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1On... HTTP 301
    https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5m... Page URL
  2. https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-tr... HTTP 302
    https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-tr... HTTP 301
    https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaX... HTTP 301
    https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatme... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • piwik\.js|piwik\.php

Page Statistics

87
Requests

94 %
HTTPS

67 %
IPv6

12
Domains

23
Subdomains

18
IPs

3
Countries

7050 kB
Transfer

19351 kB
Size

12
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://dougallgpt.com/short/nl-external?dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1 HTTP 302
    https://dougallgpt.com/short/nl-external?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1 HTTP 301
    https://api.phnxml.io/v2/nl/urlresolver?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1&pwId=146&property=dougallgpt&domain=dougallgpt.com&path=%2Fnl-external&somDomain=api.phnxml.io&somUri=%2Fv1%2Fsom%2Fclick HTTP 301
    https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons Page URL
  2. https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&article_id=5676151&article_title=Eftilagimod%20Improves%20Efficacy%20of%20Pembrolizumab%20in%20First-Line%20Treatment%20of%20Non-Small-Cell%20Lung%20Cancer&source=dougallgpt HTTP 302
    https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&article_id=5676151&article_title=Eftilagimod%20Improves%20Efficacy%20of%20Pembrolizumab%20in%20First-Line%20Treatment%20of%20Non-Small-Cell%20Lung%20Cancer&source=dougallgpt HTTP 301
    https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&url=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%253D%253D%26dp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2BImproves%2BEfficacy%2Bof%2BPembrolizumab%2Bin%2BFirst-Line%2BTreatment%2Bof%2BNon-Small-Cell%2BLung%2BCancer%26source%3Ddougallgpt&source=dougallgpt&interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw==&idhBrandId=150 HTTP 301
    https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 0
  • https://dougallgpt.com/short/nl-external?dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1 HTTP 302
  • https://dougallgpt.com/short/nl-external?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1 HTTP 301
  • https://api.phnxml.io/v2/nl/urlresolver?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&dest=article&fbId=5676151&external=true&pos=1&pwId=146&property=dougallgpt&domain=dougallgpt.com&path=%2Fnl-external&somDomain=api.phnxml.io&somUri=%2Fv1%2Fsom%2Fclick HTTP 301
  • https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Request Chain 63
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=100043417/emailid=15250419/personid=100043417/channel=website/size=520x150/geography=be/prof=12/spec=159/viewid=1000434175301724215847919/random=13155/pid=23155/CampaignID=1/interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw==/zone=articlepage/tags=CND3843,CND0396,CND2861,CND4281,CND2061,CND4356,CND3665,CND5557,CND6427,DRG07177,DRG10740,DRG04819 HTTP 301
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=53AUfFDrgFagDTtmH5gG1y0YpIvotwKQ4zWzdx1j69oRVApIv90eNQ%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D13155%2Fpid%3D23155%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215848704&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36
Request Chain 80
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=100043417/emailid=15250419/personid=100043417/channel=website/size=520x150/geography=be/prof=12/spec=159/viewid=1000434175301724215847919/random=11236/pid=21236/CampaignID=1/interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw==/zone=articlepage/tags=CND3843,CND0396,CND2861,CND4281,CND2061,CND4356,CND3665,CND5557,CND6427,DRG07177,DRG10740,DRG04819 HTTP 301
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=cH1bTRJ5hCH7_MmPZpFi9KbtaPvqX-B3FREYkYXd7kRDqEEKIdCzbg%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D11236%2Fpid%3D21236%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215851600&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36

87 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
nl-external
dougallgpt.com/
Redirect Chain
  • https://dougallgpt.com/short/nl-external?dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45105&campaignId=1591&siteId=1020&brandId=154&source=DGPTLessons&lang=en&des...
  • https://dougallgpt.com/short/nl-external?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=4...
  • https://api.phnxml.io/v2/nl/urlresolver?interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&dp=529-763330cc-117e-4957-98d8-ffeb66bceb59&nlSite=dougallgpt_smartvite&eventId=45...
  • https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNz...
31 KB
11 KB
Document
General
Full URL
https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
22f7a809824963462ef70200f0e4200eba289543e7a3d2638d0e3598c78d4b38
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b6800f8e9a23617-FRA
content-encoding
gzip
content-type
text/html
date
Wed, 21 Aug 2024 04:50:42 GMT
last-modified
Fri, 09 Aug 2024 14:57:31 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Accept-Encoding
via
1.1 934815569b3b6127560be81f148ef706.cloudfront.net (CloudFront)
x-amz-cf-id
fng2jtHUOdkRHGgabQg6paoOcV9a_b55fLspSp7YJPocpn9ktWGTBg==
x-amz-cf-pop
FRA60-P5
x-amz-id-2
sdBlomf+ZUoEc48K1fFwyKy19i5jKqpSJiKwsudcXXmuTZM3A0Efm4uqqaDZYlIhl+tlTv+khOo=
x-amz-request-id
PNM0HE7YVD5M9Z26
x-amz-server-side-encryption
AES256
x-amz-version-id
EGz2kr5Mr8nhCfDLGkDmXeBmx4F9XnRt
x-cache
Miss from cloudfront
x-content-type-options
nosniff
x-frame-options
DENY

Redirect headers

access-control-allow-origin
*
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:42 GMT
location
https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
via
1.1 fd3cce3e0bafd8b312277d0ad9f4762e.cloudfront.net (CloudFront), 1.1 7d3c59ee1b45f72158a8cbce053c8978.cloudfront.net (CloudFront)
x-amz-apigw-id
c17FZH8IDoEEOTQ=
x-amz-cf-id
EyW3RBdglYL8YleyQ5pyD12W7GJCk56H5Ml_rKjgnkF6G3tF8KdEtA==
x-amz-cf-pop
FRA56-C2 FRA56-C2
x-amzn-requestid
f6977387-8ad0-4451-8850-ebf5fca74089
x-amzn-trace-id
Root=1-66c57222-5a148d0709a3d8f44923fe72;Parent=29acb850e8f5f397;Sampled=0;lineage=b99f24ef:0
x-cache
Miss from cloudfront
css
fonts.googleapis.com/
4 KB
732 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Inter:400,700
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
8dc15522401d17a37dc042359e58af87f2633e28a83e575ac5cfed192bf8d056
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 03:04:14 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:43 GMT
css
fonts.googleapis.com/
2 KB
964 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Raleway
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
cdbcbb6ab7680b6f7ee6f09ff2a54b0e8e3eb6e758efb1c0a7fe5e71fb0da118
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 04:30:55 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:43 GMT
main.ddeaa5ea.js
dougallgpt.com/static/js/
6 MB
1 MB
Script
General
Full URL
https://dougallgpt.com/static/js/main.ddeaa5ea.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
00bec52a54e5a4ddeea9daa62243e15fd39fadfd15e1cb12db870200fed32fd7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:43 GMT
x-amz-version-id
YM2oDG2Ds_v7ACdwWc0EKNtluiQwnEjv
content-encoding
gzip
cf-cache-status
HIT
via
1.1 8b889e35789d2b97f2ba8771acc9a008.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
8SNCMGP14N9MDX8Y
x-amz-cf-pop
FRA60-P3
x-amz-server-side-encryption
AES256
age
32
x-cache
Miss from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
x-amz-id-2
c7FihxqR4PnbkiApHCbpFG2n03SQFltgZXKsAr6+s5xMfruKHDlH8WycpYU6LO3GzbHTFopzrN8=
last-modified
Fri, 09 Aug 2024 14:57:31 GMT
server
cloudflare
etag
W/"27782f97f5ad55364efa86c7bf1d7308"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
8b6800fdfeb43617-FRA
x-amz-cf-id
_gK57WU8WljHNGV7PpEdBVYJW2F_TDubeziaToIUmTNIdWPDKR3PKA==
expires
Wed, 21 Aug 2024 08:50:43 GMT
main.3799be96.css
dougallgpt.com/static/css/
2 MB
1001 KB
Stylesheet
General
Full URL
https://dougallgpt.com/static/css/main.3799be96.css
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f8464fdb9806b4b41f22b28db9cc6c535ef0fcd08bec4f27e79142562965e5de
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:43 GMT
x-amz-version-id
7tmE1PnxNZIwy_qaXqm_.mA4KoTD8AY8
content-encoding
gzip
cf-cache-status
HIT
via
1.1 2a44338adc8233e5b25aca28287a69c8.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
3VCZMJ3VYDQSQ95A
x-amz-cf-pop
FRA60-P3
x-amz-server-side-encryption
AES256
age
5877
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
qHbfJmCnXZL2zoB9sW4/ftA6eOX50zD6Z9wT4y59Ugv2VTAt/wTzV1mf/4wmjDzOcvd8tRZMMlw=
last-modified
Fri, 09 Aug 2024 14:57:31 GMT
server
cloudflare
etag
W/"d14bdeba7d2c83c589596b383a75ec55"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/css
cache-control
public, max-age=14400
cf-ray
8b6800fbdc8f3617-FRA
x-amz-cf-id
nCmt5Z31iDsEdnEcfbHyNzITRYKVY-Fn9SL5Vjv59r41MeLgcP7HFg==
expires
Wed, 21 Aug 2024 08:50:43 GMT
sasia.min.js
content.aimatch.com/js/sasia/v1/
6 KB
3 KB
Script
General
Full URL
https://content.aimatch.com/js/sasia/v1/sasia.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.17.100.131 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a2-17-100-131.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
080b836d73ad378365492df072f69365eb76bca3ad7fe715d854b5cf012a493f

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

expires
Wed, 21 Aug 2024 05:50:43 GMT
x-amz-version-id
null
content-encoding
gzip
date
Wed, 21 Aug 2024 04:50:43 GMT
last-modified
Tue, 16 Feb 2016 15:21:55 GMT
server
AmazonS3
x-amz-request-id
E4HPXVGRQ8AC1ZE8
etag
"c1a192142497cfc2d2def7217929e22b"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=3600
accept-ranges
bytes
x-datastream-cache-status
1
x-amz-id-2
RZYnFhBTMsKVpcnjmW8olgjv3MMBYoAfKHZJtL/6y772IF85UTGjCavup8oBQU3bm2Tkn6wPbKc=
content-length
2231
mnsf8hnnlu
www.clarity.ms/tag/
556 B
812 B
Script
General
Full URL
https://www.clarity.ms/tag/mnsf8hnnlu
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2620:1ec:bdf::67 , United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
9c2190e95f62f5a510aa34e31d42ecf487695e7d8144f2ec1cf57105303ce695

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

request-context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
date
Wed, 21 Aug 2024 04:50:43 GMT
x-azure-ref
20240821T045043Z-179d6ccbd55vvjvqzdx4uusd0s00000006m000000000c3qx
x-cache
CONFIG_NOCACHE
content-type
application/x-javascript
cache-control
no-cache, no-store
accept-ranges
bytes
content-length
556
expires
-1
css2
fonts.googleapis.com/
5 KB
740 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;600&display=swap
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/static/css/main.3799be96.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
14d0333bd3bc84f7662a5956639e474a4d5db164fb2e43c8aa4097fca9eeed0c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 04:50:43 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:43 GMT
clarity.js
www.clarity.ms/s/0.7.44/
64 KB
27 KB
Script
General
Full URL
https://www.clarity.ms/s/0.7.44/clarity.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2620:1ec:bdf::67 , United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
9dbecbadaa08e0d16aab217984189ff2cef37b1d741038db5a4aceba05eb1470

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:43 GMT
content-encoding
br
last-modified
Mon, 19 Aug 2024 18:56:59 GMT
etag
W/"0x8DCC080B41F78CC"
vary
Accept-Encoding
x-azure-ref
20240821T045043Z-179d6ccbd55vvjvqzdx4uusd0s00000006m000000000c3r9
content-type
application/javascript;charset=utf-8
access-control-allow-origin
*
x-ms-request-id
82ed6712-b01e-000e-47d1-f2076b000000
cache-control
public, max-age=86400
x-cache
TCP_HIT
x-ms-version
2018-03-28
x-fd-int-roxy-purgeid
51562430
nr-loader-spa-current.min.js
js-agent.newrelic.com/
60 KB
20 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-loader-spa-current.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

x-amz-version-id
q2BWEvO2EOkjCkiS79TT4xc4wiSUKSzk
content-encoding
br
via
1.1 varnish
date
Wed, 21 Aug 2024 04:50:44 GMT
strict-transport-security
max-age=300
x-amz-request-id
3WZ171YR48H0DJ9D
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
19703
x-amz-id-2
Wzq40+bMI1xJh9vJcawALsIF3KPy2Sz5qM3U6fZ4cXyO/9droLZnmTt5Nx3JbMfZHm0yThJs9to=
x-served-by
cache-fra-eddf8230141-FRA
last-modified
Tue, 06 Aug 2024 22:33:54 GMT
server
AmazonS3
etag
"2461b492ea31aade8c1fcdf135281d54"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=7200, stale-while-revalidate=600, stale-if-error=600
accept-ranges
bytes
x-cache-hits
3
collect
t.clarity.ms/
0
278 B
Ping
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: www.clarity.ms
URL: https://www.clarity.ms/s/0.7.44/clarity.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://dougallgpt.com
Date
Wed, 21 Aug 2024 04:50:44 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
piwik.js
a.dougallgpt.com/
65 KB
22 KB
Script
General
Full URL
https://a.dougallgpt.com/piwik.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
x-bot-score
77
age
5878
content-encoding
gzip
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 23 Jul 2024 15:54:28 GMT
server
cloudflare
etag
W/"669fd234-1042f"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
8b68010518808f3a-FRA
expires
Wed, 21 Aug 2024 08:50:44 GMT
verify
phnx.dougallgpt.com/v2/auth/token/
2 KB
1 KB
XHR
General
Full URL
https://phnx.dougallgpt.com/v2/auth/token/verify
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:12f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
content-encoding
gzip
via
1.1 22ec86e3f4ec676e17ef8eea76eefba2.cloudfront.net (CloudFront), 1.1 27f780feafa4114cfc67d86fca85d124.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
c2bf82e2-42ef-48fe-a12c-74cb922d8611
x-cache
Miss from cloudfront
x-amz-apigw-id
c17FyF1CDoEEb8Q=
content-length
842
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57224-6911a32b7053e96f1e4fb610;Parent=7b405a569e037c8b;Sampled=0;lineage=03d16b22:0|6f512099:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801059cd51952-FRA
x-amz-cf-id
Ll8TVf20X26EG9GmFt5mv0xUa8DYDFnjlDEzPA_7mqsx1fFucrq1mQ==
favicon.ico
dougallgpt.com/
103 KB
13 KB
Other
General
Full URL
https://dougallgpt.com/favicon.ico
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallgpt.com/nl-external
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
x-amz-version-id
pjVYr35X7GDclYIo2budQMEKexgrBbQn
via
1.1 7662c8abc46b26b811683f946db8d376.cloudfront.net (CloudFront)
cf-cache-status
REVALIDATED
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
0BEESQTBG7VQWAYX
x-amz-cf-pop
VIE50-P3
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
vPH4iikLAXupnZn3oyNsh/F21KmFVOidE6YSCZCuuTy/qQG2+wNlcoxuesu6EGOXihKrKbBM8So=
last-modified
Fri, 09 Aug 2024 14:57:31 GMT
server
cloudflare
etag
W/"61956c7ede9f7faa6867c0cae21b649b"
x-frame-options
DENY
vary
Accept-Encoding
content-type
image/vnd.microsoft.icon
cache-control
public, max-age=14400
cf-ray
8b680104dc3a3617-FRA
x-amz-cf-id
7FHAPeb-uztf_1cUqIRtkfdzwZkVcOyuHz2dlDoZDEExCJw75Jb9qA==
expires
Wed, 21 Aug 2024 08:50:44 GMT
dougall-favicon.svg
c-phnx.dougallgpt.com/assets/sites/dougallgpt/
566 B
1 KB
Other
General
Full URL
https://c-phnx.dougallgpt.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
content-encoding
7bit
via
1.1 c8ac7a019b84f0be7a6db0660bd384c0.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
MRS52-C2
age
2555
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b6801051d4918dd-FRA
x-amz-cf-id
i1-3FZ_2DKvdgyfFuNtQmTEWciBj2jq1p1nG7ZYlNM7Mt0IrVxHS0Q==
expires
Wed, 21 Aug 2024 08:50:44 GMT
nr-spa-1.264.0.min.js
js-agent.newrelic.com/
110 KB
32 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-spa-1.264.0.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

Referer
https://dougallgpt.com/
Origin
https://dougallgpt.com
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

x-amz-version-id
FkefU_LeT3SwMP9VPGnqJDvHw33LVo9Q
content-encoding
br
via
1.1 varnish
date
Wed, 21 Aug 2024 04:50:44 GMT
strict-transport-security
max-age=300
x-amz-request-id
VFMZTSY1DZ0GPFGJ
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
32013
x-amz-id-2
RlJMqb4EnUDGW3ENeeojuSPM6YN3bLC0TGVBFtk27GVS97N7M5BCTj5ZMQBK/2g5dcTBG8UyneA=
x-served-by
cache-fra-eddf8230036-FRA
last-modified
Tue, 06 Aug 2024 22:33:26 GMT
server
AmazonS3
etag
"d445c6ab99f8d2940df12996faeaccc0"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
77184
verify
phnx.dougallgpt.com/v2/auth/token/
0
0
Preflight
General
Full URL
https://phnx.dougallgpt.com/v2/auth/token/verify
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:12f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallgpt.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b6801051c5d1952-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:44 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 20a87151baa74b57c01624c82e244c6a.cloudfront.net (CloudFront), 1.1 27f780feafa4114cfc67d86fca85d124.cloudfront.net (CloudFront)
x-amz-apigw-id
c17FyG_dDoEEO3A=
x-amz-cf-id
pZV1JEmm1sF2mBNhotmCS3Ir7VAjPeT2reQA06XAk3Txuz4QK1dNfg==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
1f4036e7-4811-4127-8c99-42c4283a9329
x-cache
Miss from cloudfront
x-content-type-options
nosniff
dougall-favicon.svg
c-phnx.dougallgpt.com/assets/sites/dougallgpt/
566 B
0
Other
General
Full URL
https://c-phnx.dougallgpt.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
content-encoding
7bit
via
1.1 c8ac7a019b84f0be7a6db0660bd384c0.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
HIT
x-content-type-options
nosniff
x-amz-cf-pop
MRS52-C2
age
2555
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b6801051d4918dd-FRA
x-amz-cf-id
i1-3FZ_2DKvdgyfFuNtQmTEWciBj2jq1p1nG7ZYlNM7Mt0IrVxHS0Q==
expires
Wed, 21 Aug 2024 08:50:44 GMT
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/1/
150 B
650 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/1/NRJS-c1e44b406a79b06158d?a=538464710&sa=1&v=1.264.0&t=Unnamed%20Transaction&rst=3284&ck=0&s=505cb9a3aad73652&ref=https://dougallgpt.com/nl-external&ptid=f9c9006f5d8a743c&af=err,spa,xhr,stn,ins&be=1489&fe=1589&dc=1587&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1724215841421,%22n%22:0,%22f%22:1237,%22dn%22:1237,%22dne%22:1237,%22c%22:1237,%22s%22:1237,%22ce%22:1237,%22rq%22:1238,%22rp%22:1489,%22rpe%22:1497,%22di%22:2163,%22ds%22:3075,%22de%22:3076,%22dc%22:3076,%22l%22:3077,%22le%22:3078%7D,%22navigation%22:%7B%7D%7D
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
istio-envoy /
Resource Hash

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
server
istio-envoy
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
text/plain
access-control-allow-origin
https://dougallgpt.com
access-control-expose-headers
Date
access-control-allow-credentials
true
x-envoy-upstream-service-time
3
cross-origin-resource-policy
cross-origin
Connection
keep-alive
timing-allow-origin
https://dougallgpt.com
Content-Length
150
x-served-by
cache-fra-eddf8230058-FRA
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/events/1/
24 B
341 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/events/1/NRJS-c1e44b406a79b06158d?a=538464710&sa=1&v=1.264.0&t=Unnamed%20Transaction&rst=3368&ck=0&s=505cb9a3aad73652&ref=https://dougallgpt.com/nl-external&ptid=f9c9006f5d8a743c
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
image/gif
access-control-allow-origin
https://dougallgpt.com
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
24
x-served-by
cache-fra-eddf8230154-FRA
locale-dgpt.json
c-phnx.dougallgpt.com/assets/misc/locale/
660 KB
661 KB
XHR
General
Full URL
https://c-phnx.dougallgpt.com/assets/misc/locale/locale-dgpt.json
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
content-encoding
7bit
via
1.1 d954dd318e06aa0e69375f36dcd819de.cloudfront.net (CloudFront)
x-amz-version-id
LzvU_lUU2V3OE9Ym6V47Mgsym5nSuM1H
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P1
age
1055
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
content-length
675860
last-modified
Fri, 09 Aug 2024 14:50:30 GMT
server
cloudflare
etag
"2c0a307a443dfb9e0a93f73d61a056d4"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
application/json
access-control-allow-origin
https://dougallgpt.com
access-control-expose-headers
x-amz-server-side-encryption, x-amz-request-id, x-amz-id-2
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
8b68010708634d9d-FRA
x-amz-cf-id
YMXsoSg3HSiqitgRfYqg8ZenWwGswyo7NDqiFEF6r8eSVjqjCENUuw==
client.js
c-neml.dougallgpt.com/device/
43 KB
17 KB
Script
General
Full URL
https://c-neml.dougallgpt.com/device/client.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:12f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:44 GMT
via
1.1 62e2e45895008240d70f26081269c850.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P5
age
5877
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 16 Apr 2024 14:28:29 GMT
server
cloudflare
etag
W/"743b629c2fd75a3bf9d68ff918e30d94"
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
8b6801071ae48f34-FRA
x-amz-cf-id
PrA_eMn13mLRvjBqfN_WssuCWE7xs9oPG3XVibyBydVaUYVAqcKw0Q==
expires
Wed, 21 Aug 2024 08:50:44 GMT
Primary Request eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer
dougallmd.com/article/
Redirect Chain
  • https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwia...
  • https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNg...
  • https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsI...
  • https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWa...
31 KB
11 KB
Document
General
Full URL
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/static/js/main.ddeaa5ea.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
340e1a59c1d9a7145e4b56472a3a88c8e8289f7c9b58bf0419fcf5a8f3b825ca
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallgpt.com/nl-external
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b68010a996b1957-FRA
content-encoding
gzip
content-type
text/html
date
Wed, 21 Aug 2024 04:50:45 GMT
last-modified
Fri, 09 Aug 2024 14:57:36 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Accept-Encoding
via
1.1 0833e8be76641de099b8f4a92c7a1c4e.cloudfront.net (CloudFront)
x-amz-cf-id
4JTrPZ04ltJtA78Wa9egyMTotyErPBAh-Hc5aizlRtOSQMIK-3gb8w==
x-amz-cf-pop
FRA60-P7
x-amz-id-2
/NRKSH8Hq+CfSGiTF6S85WxhZccgsP8tYRetk3SjWAVWtbAtQAF58jHpG3lEmcrw28OgNIfuok0=
x-amz-request-id
SVZFBA2P8D7W7QS3
x-amz-server-side-encryption
AES256
x-amz-version-id
hCzyJHfc0_MyjuAC9.F9igKNfcCsdQC4
x-cache
Miss from cloudfront
x-content-type-options
nosniff
x-frame-options
DENY

Redirect headers

content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:45 GMT
location
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
via
1.1 0ece2d48b2ca1badca11fa675b7785ea.cloudfront.net (CloudFront), 1.1 7d3c59ee1b45f72158a8cbce053c8978.cloudfront.net (CloudFront)
x-amz-apigw-id
c17F4E0PDoEEexw=
x-amz-cf-id
VVyjF5DwiZth5a3JTdbK3-16995G5WXDF7rdKo9JzJCJcahaklbsfg==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
7e424e05-eed4-49bc-8545-27edd9311981
x-amzn-trace-id
Root=1-66c57225-48315c300f99b6481cbd294c;Parent=11fe06e671b036fd;Sampled=0;lineage=0551940c:0
x-cache
Miss from cloudfront
piwik.php
a.dougallgpt.com/
0
201 B
Ping
General
Full URL
https://a.dougallgpt.com/piwik.php
Requested by
Host: a.dougallgpt.com
URL: https://a.dougallgpt.com/piwik.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/8.1.29
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=utf-8

Response headers

date
Wed, 21 Aug 2024 04:50:45 GMT
content-encoding
none
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
DYNAMIC
server
cloudflare
x-bot-score
72
x-powered-by
PHP/8.1.29
access-control-allow-origin
https://dougallgpt.com
access-control-allow-credentials
true
cf-ray
8b6801071a208f3a-FRA
alt-svc
h3=":443"; ma=86400
collect
t.clarity.ms/
0
278 B
XHR
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
application/x-clarity-gzip
Referer
https://dougallgpt.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://dougallgpt.com
Date
Wed, 21 Aug 2024 04:50:45 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
RelevantID4.js
dougallgpt.com/prx/rvid/
191 KB
35 KB
XHR
General
Full URL
https://dougallgpt.com/prx/rvid/RelevantID4.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=45105&nl_campaignid=1591&profileId=334121886&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktNzYzMzMwY2MtMTE3ZS00OTU3LTk4ZDgtZmZlYjY2YmNlYjU5IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzI0MTc2ODk1LCJleHAiOjE3MjY3Njg4OTV9.ARFwIpl5BaZNQloUJNVdYnu8sm_C9D-325PJPvnLEJ4%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=1&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&interactionId=GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw%3D%3D&lang=en&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:13f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/nl-external
tracestate
2926632@nr=0-1-3151430-538464710-7950c80e076b1952----1724215845102, 2926632@nr=0-1-3151430-538464710-14410efbc3da8c15----1724215845102
traceparent
00-058b039b11f47e50c2849542a550e8d2-7950c80e076b1952-01, 00-99f69fec37a52e04a1c8fc41449e0b86-14410efbc3da8c15-01
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
newrelic
eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDcxMCIsImlkIjoiNzk1MGM4MGUwNzZiMTk1MiIsInRyIjoiMDU4YjAzOWIxMWY0N2U1MGMyODQ5NTQyYTU1MGU4ZDIiLCJ0aSI6MTcyNDIxNTg0NTEwMiwidGsiOiIyOTI2NjMyIn19, eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDcxMCIsImlkIjoiMTQ0MTBlZmJjM2RhOGMxNSIsInRyIjoiOTlmNjlmZWMzN2E1MmUwNGExYzhmYzQxNDQ5ZTBiODYiLCJ0aSI6MTcyNDIxNTg0NTEwMiwidGsiOiIyOTI2NjMyIn19

Response headers

date
Wed, 21 Aug 2024 04:50:45 GMT
via
1.1 1f49a084ca923f375f74b42fa36ef428.cloudfront.net (CloudFront), 1.1 b43c04a791e8dcb8ddb6bb0847fcf95a.cloudfront.net (CloudFront)
content-encoding
gzip
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA50-C1, FRA60-P3
age
32
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Wed, 03 Apr 2024 13:27:29 GMT
server
cloudflare
etag
W/"ecfcfbb1297ac0d98b5afa9c144995a1"
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
8b680107ee7e3617-FRA
x-amz-cf-id
cNbyfKgcmyWXybhwfi6K0cA4NU6EycRje7MMskzzKyI2eagtWhIyFw==
expires
Wed, 21 Aug 2024 08:50:45 GMT
UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1ZL7.woff2
fonts.gstatic.com/s/inter/v18/
47 KB
48 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v18/UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1ZL7.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Inter:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://dougallgpt.com
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Tue, 20 Aug 2024 13:55:59 GMT
x-content-type-options
nosniff
age
53686
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
48444
x-xss-protection
0
last-modified
Mon, 29 Jul 2024 22:51:01 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 20 Aug 2025 13:55:59 GMT
dedupe
rvid.imperium.com/
0
0

dedupe
rvid.imperium.com/
0
0

css
fonts.googleapis.com/
4 KB
732 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Inter:400,700
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
8dc15522401d17a37dc042359e58af87f2633e28a83e575ac5cfed192bf8d056
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 03:04:14 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:45 GMT
css
fonts.googleapis.com/
2 KB
964 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Raleway
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
cdbcbb6ab7680b6f7ee6f09ff2a54b0e8e3eb6e758efb1c0a7fe5e71fb0da118
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 04:37:24 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:45 GMT
main.a3bd0e9d.js
dougallmd.com/static/js/
6 MB
1 MB
Script
General
Full URL
https://dougallmd.com/static/js/main.a3bd0e9d.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
29c5acbb8505d262f566e28ba776719b7a01601e7c45fbfd1072f84efedd0bac
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:45 GMT
x-amz-version-id
5P3LJCNElQLOdPvG5bD8M8zzb3T8gBmg
content-encoding
gzip
cf-cache-status
HIT
via
1.1 67b46acac5b2604c39c0417497d3d218.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
YP8E0APR28Q5SCDQ
x-amz-cf-pop
MUC50-P4
x-amz-server-side-encryption
AES256
age
4
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
x0XAqbw83NtV86Vlyfbn0xptUK9ToJ91cc+mqRfDYPX1O8L9n2dnJinLsi1BgW6QoFVD8Bv/lqo=
last-modified
Fri, 09 Aug 2024 14:57:36 GMT
server
cloudflare
etag
W/"b10f4a3e77af3873c0f122ffce313329"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
8b68010c9b021957-FRA
x-amz-cf-id
pYUSmLntRt3DBqB0bSCXRpuwqhZqMD3sy8KMwJsXiUPuFxO-UPvwsg==
expires
Wed, 21 Aug 2024 08:50:45 GMT
main.c1fba5f9.css
dougallmd.com/static/css/
2 MB
1002 KB
Stylesheet
General
Full URL
https://dougallmd.com/static/css/main.c1fba5f9.css
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
31069d09d2a1f3fd36e0c738a6776f0ebac4fe98ebe143544047381594187aaf
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:45 GMT
x-amz-version-id
5EtBQjje8EWRrXja6HeBpNt75jLs58e5
content-encoding
gzip
cf-cache-status
HIT
via
1.1 a54ec0c537d142d7248512cab0b896f8.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
11CV40DB8623VNK9
x-amz-cf-pop
DUS51-P3
x-amz-server-side-encryption
AES256
age
4
x-cache
Miss from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
x-amz-id-2
8TW4LvEN5q2oRpjRsGrajpP68pEfUALll/5WjWKBUbDGeyHAhdJe5/iDRSWFka2sjuTinAnJkSc=
last-modified
Fri, 09 Aug 2024 14:57:36 GMT
server
cloudflare
etag
W/"8d8fc218590c9c3ad461f893c2c7bb80"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/css
cache-control
public, max-age=14400
cf-ray
8b68010c0a731957-FRA
x-amz-cf-id
5RoeirvJ2yYZDj-pjY48xmTi5LVNxalsc6O4yYFExJCI0S4FZmJwUg==
expires
Wed, 21 Aug 2024 08:50:45 GMT
sasia.min.js
content.aimatch.com/js/sasia/v1/
6 KB
3 KB
Script
General
Full URL
https://content.aimatch.com/js/sasia/v1/sasia.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.17.100.131 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a2-17-100-131.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
080b836d73ad378365492df072f69365eb76bca3ad7fe715d854b5cf012a493f

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

expires
Wed, 21 Aug 2024 05:50:45 GMT
x-amz-version-id
null
content-encoding
gzip
date
Wed, 21 Aug 2024 04:50:45 GMT
last-modified
Tue, 16 Feb 2016 15:21:55 GMT
server
AmazonS3
x-amz-request-id
E4HPXVGRQ8AC1ZE8
etag
"c1a192142497cfc2d2def7217929e22b"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=3600
accept-ranges
bytes
x-datastream-cache-status
1
x-amz-id-2
RZYnFhBTMsKVpcnjmW8olgjv3MMBYoAfKHZJtL/6y772IF85UTGjCavup8oBQU3bm2Tkn6wPbKc=
content-length
2231
mnsffrn8tx
www.clarity.ms/tag/
538 B
794 B
Script
General
Full URL
https://www.clarity.ms/tag/mnsffrn8tx
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2620:1ec:bdf::67 , United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
b0288b92a1aabfc0dee98b1efa4620afe04ca663aaee5c8fe42d18900cc4f88e

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

request-context
appId=cid-v1:b1d896b3-bec7-448b-b764-240152e813e8
date
Wed, 21 Aug 2024 04:50:46 GMT
x-azure-ref
20240821T045045Z-179d6ccbd554qgn9uzsq48atbc000000082g00000000kqrd
x-cache
CONFIG_NOCACHE
content-type
application/x-javascript
cache-control
no-cache, no-store
accept-ranges
bytes
content-length
538
expires
-1
css2
fonts.googleapis.com/
5 KB
763 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;600&display=swap
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/static/css/main.c1fba5f9.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
14d0333bd3bc84f7662a5956639e474a4d5db164fb2e43c8aa4097fca9eeed0c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Wed, 21 Aug 2024 04:50:46 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Wed, 21 Aug 2024 04:50:46 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 21 Aug 2024 04:50:46 GMT
clarity.js
www.clarity.ms/s/0.7.44/
64 KB
27 KB
Script
General
Full URL
https://www.clarity.ms/s/0.7.44/clarity.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2620:1ec:bdf::67 , United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
9dbecbadaa08e0d16aab217984189ff2cef37b1d741038db5a4aceba05eb1470

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:46 GMT
content-encoding
br
last-modified
Sun, 18 Aug 2024 10:51:58 GMT
etag
W/"0x8DCBF73C8545D76"
vary
Accept-Encoding
x-azure-ref
20240821T045046Z-179d6ccbd554qgn9uzsq48atbc000000082g00000000kqrw
content-type
application/javascript;charset=utf-8
access-control-allow-origin
*
x-ms-request-id
348d170a-b01e-0043-0e08-f2c887000000
cache-control
public, max-age=86400
x-cache
TCP_HIT
x-ms-version
2018-03-28
x-fd-int-roxy-purgeid
51562430
collect
t.clarity.ms/
0
277 B
XHR
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/x-clarity-gzip
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://dougallmd.com
Date
Wed, 21 Aug 2024 04:50:46 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
nr-loader-spa-current.min.js
js-agent.newrelic.com/
60 KB
20 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-loader-spa-current.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
66a42bbaebe860b8847caebaaa12476581b95f5d9d43caadbbcdfffecd4055cc
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

x-amz-version-id
q2BWEvO2EOkjCkiS79TT4xc4wiSUKSzk
content-encoding
br
via
1.1 varnish
date
Wed, 21 Aug 2024 04:50:46 GMT
strict-transport-security
max-age=300
x-amz-request-id
3WZ171YR48H0DJ9D
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
19703
x-amz-id-2
Wzq40+bMI1xJh9vJcawALsIF3KPy2Sz5qM3U6fZ4cXyO/9droLZnmTt5Nx3JbMfZHm0yThJs9to=
x-served-by
cache-fra-eddf8230150-FRA
last-modified
Tue, 06 Aug 2024 22:33:54 GMT
server
AmazonS3
etag
"2461b492ea31aade8c1fcdf135281d54"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=7200, stale-while-revalidate=600, stale-if-error=600
accept-ranges
bytes
x-cache-hits
1
collect
t.clarity.ms/
0
277 B
Ping
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: www.clarity.ms
URL: https://www.clarity.ms/s/0.7.44/clarity.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://dougallmd.com
Date
Wed, 21 Aug 2024 04:50:47 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
piwik.js
a.dougallmd.com/
65 KB
22 KB
Script
General
Full URL
https://a.dougallmd.com/piwik.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b39abd9035f703b76dfed940898d572b9864f676eb1912a9142f0639dca6b2ce
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
x-bot-score
89
age
5
content-encoding
gzip
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 23 Jul 2024 15:54:28 GMT
server
cloudflare
etag
W/"669fd234-1042f"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
8b68011458d51957-FRA
expires
Wed, 21 Aug 2024 08:50:47 GMT
verify
phnx.dougallmd.com/v2/auth/token/
2 KB
2 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/auth/token/verify
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
830ccd17f3d1b85d983bfb784d29e1ffc57e4f62f8913c819119a6704711ed27
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
content-encoding
gzip
via
1.1 f13110b40e6214ad566c753a838f49f4.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
946d4085-2e1e-4f58-9a16-7c1a82a3a730
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GNF7OjoEEHBw=
content-length
942
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57227-7a5586a968870ccc4c8a290f;Parent=194725d452c29b09;Sampled=0;lineage=03d16b22:0|6f512099:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801164cd91989-FRA
x-amz-cf-id
6SkG_77Y07L7B5tQSjTjyhicFeQa_ONR_a8T0NEm7_uQehy1-1d3eg==
verify
phnx.dougallmd.com/v2/auth/token/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/auth/token/verify
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b6801158c4e1989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:47 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 d05d62f18b6532eb36f4d53b3337857c.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GMFqtDoEER0g=
x-amz-cf-id
Ec__VzKuGUj1nFl_is6Cedr2lE4DCmP2MQ-Ln0htuLq2g-THvrsYVQ==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
2c1d1c47-ded2-40b5-a67c-08331cb70740
x-cache
Miss from cloudfront
x-content-type-options
nosniff
favicon.ico
dougallmd.com/
103 KB
13 KB
Other
General
Full URL
https://dougallmd.com/favicon.ico
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
be30663f2e8e90a0f13fe1a1ab2a72e30d55fbcdc0f75da37f9d69d7a51fba47
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
x-amz-version-id
y1ueriMB46.rTHXa4tqiJNggwDiDyzCt
via
1.1 8da78542dac6b4328eb443200c30bbfe.cloudfront.net (CloudFront)
cf-cache-status
HIT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
FCPWMT1GB8CS9CB4
x-amz-cf-pop
AMS1-C1
x-amz-server-side-encryption
AES256
age
5
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
2WMePORhfoyFQdTocAlToidoMK7GrIx9PLenYDZ2xqXQEjdX9Us9YGUbQcIUnGwWExA0M/Jwxss=
last-modified
Fri, 09 Aug 2024 14:57:36 GMT
server
cloudflare
etag
W/"61956c7ede9f7faa6867c0cae21b649b"
x-frame-options
DENY
vary
Accept-Encoding
content-type
image/vnd.microsoft.icon
cache-control
public, max-age=14400
cf-ray
8b68011448c91957-FRA
x-amz-cf-id
VzNIzibVIU9pIia8uk3LIpFrK-UC16MvigtrdwU974l-r3HGUlj4hw==
expires
Wed, 21 Aug 2024 08:50:47 GMT
dougall-favicon.svg
c-phnx.dougallmd.com/assets/sites/dougallgpt/
566 B
1 KB
Other
General
Full URL
https://c-phnx.dougallmd.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d7e43ddf3870d3a17d97dd1956b94eced8d3301f9bfdef669b9f52a04d71a9e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
content-encoding
7bit
via
1.1 59d552fe007f8133d3f016164f2c79aa.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P10
age
5
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b680114890b1957-FRA
x-amz-cf-id
R5XzM89wMCLi-bpwc0Dtkgfq1HZ99Q0aSznTyL_qcnz2SMAMrGn6ZQ==
expires
Wed, 21 Aug 2024 08:50:47 GMT
dougall-favicon.svg
c-phnx.dougallmd.com/assets/sites/dougallgpt/
566 B
0
Other
General
Full URL
https://c-phnx.dougallmd.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d7e43ddf3870d3a17d97dd1956b94eced8d3301f9bfdef669b9f52a04d71a9e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
content-encoding
7bit
via
1.1 59d552fe007f8133d3f016164f2c79aa.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
HIT
x-content-type-options
nosniff
x-amz-cf-pop
FRA56-P10
age
5
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b680114890b1957-FRA
x-amz-cf-id
R5XzM89wMCLi-bpwc0Dtkgfq1HZ99Q0aSznTyL_qcnz2SMAMrGn6ZQ==
expires
Wed, 21 Aug 2024 08:50:47 GMT
nr-spa-1.264.0.min.js
js-agent.newrelic.com/
110 KB
32 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-spa-1.264.0.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3e1292bc5ba29cb4eedbe81561ac86bd0dce1129a3262dd7033669c42b64ef20
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

Referer
https://dougallmd.com/
Origin
https://dougallmd.com
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

x-amz-version-id
FkefU_LeT3SwMP9VPGnqJDvHw33LVo9Q
content-encoding
br
via
1.1 varnish
date
Wed, 21 Aug 2024 04:50:47 GMT
strict-transport-security
max-age=300
x-amz-request-id
VFMZTSY1DZ0GPFGJ
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
32013
x-amz-id-2
RlJMqb4EnUDGW3ENeeojuSPM6YN3bLC0TGVBFtk27GVS97N7M5BCTj5ZMQBK/2g5dcTBG8UyneA=
x-served-by
cache-fra-eddf8230133-FRA
last-modified
Tue, 06 Aug 2024 22:33:26 GMT
server
AmazonS3
etag
"d445c6ab99f8d2940df12996faeaccc0"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
504432
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/1/
150 B
727 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/1/NRJS-c1e44b406a79b06158d?a=538464022&sa=1&v=1.264.0&t=Unnamed%20Transaction&rst=2163&ck=0&s=3011ab77ee872d0b&ref=https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&ptid=f6c810f5a0182d68&af=err,spa,xhr,stn,ins&be=668&fe=1175&dc=1154&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1724215845069,%22n%22:0,%22f%22:464,%22dn%22:464,%22dne%22:464,%22c%22:464,%22s%22:464,%22ce%22:464,%22rq%22:467,%22rp%22:668,%22rpe%22:676,%22di%22:1039,%22ds%22:1822,%22de%22:1822,%22dc%22:1823,%22l%22:1825,%22le%22:1843%7D,%22navigation%22:%7B%7D%7D
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.85.3 , Ireland, ASN206998 (NEW-2, IE),
Reverse DNS
Software
cloudflare /
Resource Hash
5293bff26fd4174a579e3d861da7755b097f4a1519c88b7dd9b83ea0a60b2e13

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Wed, 21 Aug 2024 04:50:47 GMT
Content-Encoding
gzip
CF-Cache-Status
DYNAMIC
Transfer-Encoding
chunked
x-envoy-upstream-service-time
3
cross-origin-resource-policy
cross-origin
Connection
keep-alive
Server
cloudflare
Vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://dougallmd.com
access-control-expose-headers
Date
access-control-allow-credentials
true
CF-Ray
8b6801157ccf917a-FRA
timing-allow-origin
https://dougallmd.com
collect
t.clarity.ms/
0
277 B
XHR
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/x-clarity-gzip
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://dougallmd.com
Date
Wed, 21 Aug 2024 04:50:47 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/events/1/
24 B
401 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/events/1/NRJS-c1e44b406a79b06158d?a=538464022&sa=1&v=1.264.0&t=Unnamed%20Transaction&rst=2459&ck=0&s=3011ab77ee872d0b&ref=https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&ptid=f6c810f5a0182d68
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.85.3 , Ireland, ASN206998 (NEW-2, IE),
Reverse DNS
Software
cloudflare /
Resource Hash
0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Wed, 21 Aug 2024 04:50:47 GMT
CF-Cache-Status
DYNAMIC
Server
cloudflare
Vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
https://dougallmd.com
access-control-allow-credentials
true
Connection
keep-alive
CF-Ray
8b6801171fef917a-FRA
Content-Length
24
locale-dgpt.json
c-phnx.dougallmd.com/assets/misc/locale/
660 KB
661 KB
XHR
General
Full URL
https://c-phnx.dougallmd.com/assets/misc/locale/locale-dgpt.json
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
71e4e0ab3f8634d725b0c627c7dd80110bb24cc2d4a36687e268c3fd9148d3da
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
content-encoding
7bit
via
1.1 6fa384f51cde51d7c86ee18d17ac3eaa.cloudfront.net (CloudFront)
x-amz-version-id
LzvU_lUU2V3OE9Ym6V47Mgsym5nSuM1H
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P10
age
63447
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
content-length
675860
last-modified
Fri, 09 Aug 2024 14:50:30 GMT
server
cloudflare
etag
"2c0a307a443dfb9e0a93f73d61a056d4"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
application/json
access-control-allow-origin
https://dougallmd.com
access-control-expose-headers
x-amz-server-side-encryption, x-amz-request-id, x-amz-id-2
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
8b68011828b618e2-FRA
x-amz-cf-id
O5mbQXSq34QuwZa3G-8xvq_x3J_n71OLa8yay17jK3efLt1selX1nA==
client.js
c-neml.dougallmd.com/device/
43 KB
17 KB
Script
General
Full URL
https://c-neml.dougallmd.com/device/client.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
263468562ac0f3496f0b7f8860b479f9f49d55e746aa909a47ad1a1e94f9cf62
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
via
1.1 00746b020527dcdbeca0dab6f6de299a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P1
age
4
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 16 Apr 2024 14:28:29 GMT
server
cloudflare
etag
W/"743b629c2fd75a3bf9d68ff918e30d94"
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
8b6801182bff1957-FRA
x-amz-cf-id
Cybtznx62C-Y3wiTqhQfsTzc_46fnPHhvAsoizRFw_WVfeE-bqKMZg==
expires
Wed, 21 Aug 2024 08:50:47 GMT
RelevantID4.js
dougallmd.com/prx/rvid/
191 KB
36 KB
XHR
General
Full URL
https://dougallmd.com/prx/rvid/RelevantID4.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cdb617c30321149f35fe4e71ccde5d7a3aaea47d312a7d208b2cb245f46f0cd7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer
tracestate
2926632@nr=0-1-3151430-538464022-560bb8cc96eed77d----1724215847747, 2926632@nr=0-1-3151430-538464022-42a3679f49a027e8----1724215847747
traceparent
00-f8118b07e66a45c6d38458a09ce45d00-560bb8cc96eed77d-01, 00-7a2402f066396d4f60eeeb4c41d7eab0-42a3679f49a027e8-01
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
newrelic
eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDAyMiIsImlkIjoiNTYwYmI4Y2M5NmVlZDc3ZCIsInRyIjoiZjgxMThiMDdlNjZhNDVjNmQzODQ1OGEwOWNlNDVkMDAiLCJ0aSI6MTcyNDIxNTg0Nzc0NywidGsiOiIyOTI2NjMyIn19, eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDAyMiIsImlkIjoiNDJhMzY3OWY0OWEwMjdlOCIsInRyIjoiN2EyNDAyZjA2NjM5NmQ0ZjYwZWVlYjRjNDFkN2VhYjAiLCJ0aSI6MTcyNDIxNTg0Nzc0NywidGsiOiIyOTI2NjMyIn19

Response headers

date
Wed, 21 Aug 2024 04:50:47 GMT
via
1.1 cdb2dba3874dd4d7b53213b8c63a0996.cloudfront.net (CloudFront), 1.1 256cd380c9790a2b71d68709829caa18.cloudfront.net (CloudFront)
content-encoding
gzip
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA50-C1, FRA60-P7
age
4
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Wed, 03 Apr 2024 13:27:29 GMT
server
cloudflare
etag
W/"ecfcfbb1297ac0d98b5afa9c144995a1"
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
8b6801187c501957-FRA
x-amz-cf-id
QZ-clr7RIXw9bZJhSfqqRjEiBER5Ry6CExcLp-yIJEBQu09xYb7UJw==
expires
Wed, 21 Aug 2024 08:50:47 GMT
url
phnx.dougallmd.com/v2/fb/search/article/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/url
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b68011a4fad1989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:48 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 f13110b40e6214ad566c753a838f49f4.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GUFSijoEEcag=
x-amz-cf-id
akZxUaWwZ5SJ2UpPrsrmE3oQmWvGnrQ5tgu4lO2bXr_KfvJCKOmVmw==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
5d203fbc-2c8b-430c-a7ea-cbc058f347f8
x-cache
Miss from cloudfront
x-content-type-options
nosniff
misc
phnx.dougallmd.com/v2/content/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b68011a4faf1989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:48 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 c0c6d7afa25d841027d75444425d2010.cloudfront.net (CloudFront), 1.1 22b9ddafebf39d72780d68dad970d218.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GUEBrDoEEayg=
x-amz-cf-id
gxqCzkq--mtqyz9SeJ6MDL9cqBAlWgUCVPLKNKo9aGwsacqV8TY0zA==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
22cca915-a94e-4490-90a0-fb5e405886e9
x-cache
Miss from cloudfront
x-content-type-options
nosniff
misc
phnx.dougallmd.com/v2/content/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b68011a4fb21989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:48 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 e1f996a9009532eeea33edfd32ef3240.cloudfront.net (CloudFront), 1.1 7d3c59ee1b45f72158a8cbce053c8978.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GTGr0DoEEgcg=
x-amz-cf-id
bgDSf72ybHkiFnebnLFuwQEHutuZE6BeQbO4v0hn4m2DyJHy_Pj18w==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
2f28b357-4011-46ec-9c5a-5ab72250ea6a
x-cache
Miss from cloudfront
x-content-type-options
nosniff
UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1ZL7.woff2
fonts.gstatic.com/s/inter/v18/
47 KB
48 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v18/UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1ZL7.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Inter:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f052ee44c3728dfd23aba8a4567150bc314d23903026fbb6ad089422c2df56af
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://dougallmd.com
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Tue, 20 Aug 2024 13:55:59 GMT
x-content-type-options
nosniff
age
53689
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
48444
x-xss-protection
0
last-modified
Mon, 29 Jul 2024 22:51:01 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 20 Aug 2025 13:55:59 GMT
dougallmd-logo.svg
c-phnx.dougallmd.com/assets/sites/dougallgpt/
10 KB
10 KB
Image
General
Full URL
https://c-phnx.dougallmd.com/assets/sites/dougallgpt/dougallmd-logo.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0422fb3d56ade626ee2c7ad03240a7fe5aca7d1aa80fd74dedb1cec16793bd2b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
7bit
via
1.1 98bb66c97d4f153aac116d087b36dc40.cloudfront.net (CloudFront)
x-amz-version-id
NP_xSMNm1Zo0H.Uua1InU0PHD9Fjz3Nm
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
DUS51-P2
age
5
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
9910
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"029350809c8aa6ab979e5f15a1accbc4"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b68011a3ea01957-FRA
x-amz-cf-id
E1xa0Lv4xYFxL-OnwBBc6OgSiOey741vUoPhbcFBUK-rr9yhAIGslw==
expires
Wed, 21 Aug 2024 08:50:48 GMT
url
phnx.dougallmd.com/v2/fb/search/article/
5 KB
3 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/url
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
42cce6ad4e53aec4dcdc27b1d59b5bab4fdb5613976f557e413fd9f8b870e27d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
gzip
via
1.1 f61953901038b0c4b4c82c311140f1b8.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
e439188b-1a2a-4ccd-993f-59cc159cfad0
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GVGSgDoEEVuw=
content-length
2159
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57228-226de70c6ba8387916f231f2;Parent=3f490b953b144fed;Sampled=0;lineage=03d16b22:0|03f65052:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b68011ad81c1989-FRA
x-amz-cf-id
YIJK4oUMzKCfujZnK6j0YHBtdFC6pJnq_1uPsTb8-3X8ETY0nEm23w==
misc
phnx.dougallmd.com/v2/content/
51 KB
20 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ec490000fb0d17db6839f168bef62c9af02cf7e7b12ba7f9901096318c21b48e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
gzip
via
1.1 0e37105a96e87c22ff4981659a6dc176.cloudfront.net (CloudFront), 1.1 22b9ddafebf39d72780d68dad970d218.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
2199a6c8-0335-444c-9c43-883df130e861
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GUE70DoEEsMw=
content-length
19920
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57228-25a389f721bd376167e69e36;Parent=1231294c170b2c68;Sampled=0;lineage=03d16b22:0|accbd57e:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b68011af82d1989-FRA
x-amz-cf-id
ngfuYZvhTL5p99sXlgUZOhc7_-a4L5DAqfGbrAuN2D-7vdruZSaGXw==
misc
phnx.dougallmd.com/v2/content/
52 KB
9 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d9b7a5cf59c5af6c995821e4a80ef57ab0e69eaf9b7ecc995824b4a33bea9b12
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
gzip
via
1.1 7b20af4202adb6ef25a7920ed74908dc.cloudfront.net (CloudFront), 1.1 7d3c59ee1b45f72158a8cbce053c8978.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
7ba94b22-3cae-4006-ad9c-eec9136f61a5
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GUG02joEEA3Q=
content-length
8141
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57228-70d58a2267d772952d7e0c07;Parent=4785b8ebda572242;Sampled=0;lineage=03d16b22:0|accbd57e:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b68011aaff51989-FRA
x-amz-cf-id
GNFXELLMS_mGnT4WBzfESG0iVF81EpiPBKb7J_EDD1HZahVqoZVHlA==
dedupe
rvid.imperium.com/
0
0
Preflight
General
Full URL
https://rvid.imperium.com/dedupe
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.206.159.125 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-159-125.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-clientid
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
content-type,x-clientid
access-control-allow-methods
POST
access-control-allow-origin
*
date
Wed, 21 Aug 2024 04:50:48 GMT
server
Kestrel
dedupe
rvid.imperium.com/
2 KB
2 KB
XHR
General
Full URL
https://rvid.imperium.com/dedupe
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.206.159.125 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-159-125.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash
2a8150e731c150336843a4ff35691530257467c0e6a2cc7d6aa610b6ec103db8

Request headers

Referer
https://dougallmd.com/
X-ClientID
BC170856-91EA-11ED-A210-1264B5C78F33
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

access-control-allow-origin
*
date
Wed, 21 Aug 2024 04:50:48 GMT
server
Kestrel
content-length
2078
content-type
application/json; charset=utf-8
rvid
api.neml.io/device/
51 B
828 B
XHR
General
Full URL
https://api.neml.io/device/rvid
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.161.82.20 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-3-161-82-20.fra56.r.cloudfront.net
Software
/
Resource Hash
3c8edd755fa89739596a7cfaf5f04fd78c4fd745d0e9cbae518cea1f23fce166
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
gzip
via
1.1 13c8b9a0a39ad1238a922185ad5547fc.cloudfront.net (CloudFront), 1.1 ecc31e9f7b98bdd8a55967baa6e36ad8.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
x-amz-cf-pop
FRA60-P10, FRA56-P10
x-amzn-requestid
9603c973-03a5-496f-adbf-ed684d48f821
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GaHeYDoEEvMg=
content-length
71
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
x-amzn-trace-id
Root=1-66c57228-19146864113c5674455e412d;Parent=090007a4ddeea079;Sampled=0;lineage=b9d4f140:0
vary
Origin
access-control-allow-methods
POST, OPTIONS
content-type
application/json
access-control-allow-origin
https://dougallmd.com
x-frame-options
SAMEORIGIN
access-control-allow-credentials
true
access-control-allow-headers
*, Content-Type, Authorization
x-amz-cf-id
DFUZN-qS0pmvgVncpcLiC3oQB8zEmQhj3mWbfEMSt9bT6n5UURpvLw==
dgan
api.phnxml.io/v2/content/
Redirect Chain
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=100043417/emailid=15250419/personid=100043417/channel=website/size=520x150/geography=be/prof=12/spec=159/viewid=10...
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=53AUfFDrgFagDTtmH5gG1y0YpIvotwKQ4zWzdx1j69oRVApIv90eNQ%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fpropert...
2 KB
1 KB
XHR
General
Full URL
https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=53AUfFDrgFagDTtmH5gG1y0YpIvotwKQ4zWzdx1j69oRVApIv90eNQ%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D13155%2Fpid%3D23155%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215848704&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36
Protocol
H2
Server
2600:9000:211e:8600:f:e0ca:fec0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
74a6da4492e3e985e3222a474f4b1058d5b13b709b8264664c426b8a57c1927a

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:48 GMT
content-encoding
gzip
via
1.1 ecb3ea567a6c6095a23354fbdc938128.cloudfront.net (CloudFront), 1.1 6c7a5d26be7fb35284e54d321f16b6f6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
a6e64d0f-0cba-4f22-bca6-81fa7c485543
x-amzn-trace-id
Root=1-66c57228-0d70ddc410cb0c84438f6844;Parent=58816d68fa3ace5d;Sampled=0;lineage=096f8394:0
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
x-amz-apigw-id
c17GbE1lDoEEJoA=
content-length
696
x-amz-cf-id
d_XT_b0WW0ioHez6OBQa7GzeLr-rzCZq1FJKS2HiRZtJfWeiAhpgYw==

Redirect headers

date
Wed, 21 Aug 2024 04:50:48 GMT
via
1.1 a5010656f4f762c0fdffac3448496b86.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P7
x-cache
Miss from cloudfront
location
https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=53AUfFDrgFagDTtmH5gG1y0YpIvotwKQ4zWzdx1j69oRVApIv90eNQ%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D13155%2Fpid%3D23155%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215848704&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36
access-control-allow-origin
*
access-control-expose-headers
*
cf-ray
8b68011e2a741989-FRA
alt-svc
h3=":443"; ma=86400
content-length
0
x-amz-cf-id
53AUfFDrgFagDTtmH5gG1y0YpIvotwKQ4zWzdx1j69oRVApIv90eNQ==
collect
t.clarity.ms/
0
277 B
XHR
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/x-clarity-gzip
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://dougallmd.com
Date
Wed, 21 Aug 2024 04:50:48 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
score
phnx.dougallmd.com/v1/ugc/
14 B
763 B
XHR
General
Full URL
https://phnx.dougallmd.com/v1/ugc/score
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e0ef60554523e2837de0dd9321a3463632d8120d18bef726251f29fdf3ed6bbb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:50 GMT
content-encoding
gzip
via
1.1 e75bff6012758ccb55ff41b176b32342.cloudfront.net (CloudFront), 1.1 7d3c59ee1b45f72158a8cbce053c8978.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
7b23fb71-c24d-41c8-aafd-e6c883aa32b5
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GiE6DDoEEYbQ=
content-length
34
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57229-549c924e78f3d275137a7460;Parent=3df96279ce2be198;Sampled=0;lineage=03d16b22:0|cc122f59:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801230e351989-FRA
x-amz-cf-id
wiPRHVUaon814D6lW4z7Bt22Gyehdc2kA_ybBcB5MoW4FCwFGOD5Zw==
publishers.json
c-phnx.dougallmd.com/assets/newsletter/dg/journal_logos/
38 KB
9 KB
XHR
General
Full URL
https://c-phnx.dougallmd.com/assets/newsletter/dg/journal_logos/publishers.json
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0b10b6a0c25bf5a0c51be30c5b579e5c50e4836a9e05c915e4a261f3ff8e0fa7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:49 GMT
x-amz-version-id
null
content-encoding
gzip
cf-cache-status
DYNAMIC
via
1.1 6fa384f51cde51d7c86ee18d17ac3eaa.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P10
age
66448
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Mon, 14 Feb 2022 17:08:42 GMT
server
cloudflare
etag
W/"2185b4144fa7db343ee09a05494bd3e7"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
application/json
access-control-allow-origin
https://dougallmd.com
access-control-expose-headers
x-amz-server-side-encryption, x-amz-request-id, x-amz-id-2
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-credentials
true
cf-ray
8b680120ff9018e2-FRA
x-amz-cf-id
4Pew8Uunxxn1F5mlhNtX2NNmrw_BWeJ7Cd2ozpkLyzn8nqCRu4Fdpw==
score
phnx.dougallmd.com/v1/ugc/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v1/ugc/score
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b680120fc981989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:49 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 7b20af4202adb6ef25a7920ed74908dc.cloudfront.net (CloudFront), 1.1 22b9ddafebf39d72780d68dad970d218.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GeHDcDoEEH_g=
x-amz-cf-id
ZInuT_ifAnhEeiTxFGKCaZlY9u03X1E88vth_M23CbcbqXpmp9EK_g==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
2a75b6b8-aea4-46ca-a6c9-b3dacc0bab3e
x-cache
Miss from cloudfront
x-content-type-options
nosniff
150208278-ad2.png
c.peerview.com/ads/
137 KB
138 KB
Image
General
Full URL
https://c.peerview.com/ads/150208278-ad2.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2761:8200:14:47ee:23c0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
8ea0386c8c85bf07ee2bba8aa125f9bfc251f4d9f92373ad107315ec25db61ee

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Sun, 11 Aug 2024 09:15:01 GMT
x-amz-version-id
IivF8P44UW6EYZ7IJEt5l2LbO3mAI8bP
via
1.1 d60e84ebd0183f97f50eb1677fb4b7be.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA60-P8
age
848149
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
content-length
140713
last-modified
Thu, 21 Mar 2024 22:12:51 GMT
server
AmazonS3
etag
"b69e030eeff7f9d2aac249f4df4a0976"
vary
Origin
content-type
image/png
accept-ranges
bytes
x-amz-cf-id
UuCTluFsUvxBw2wFh2AWO-fVP4vXkim2Oiro3OOkW5ImcQNGMAbb6g==
river
phnx.dougallmd.com/v2/fb/search/article/
22 KB
5 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/river
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6c10c3d9c5fff79cdbbb807202986f93f562e2205abdb3177fc19086fc62cf0f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:49 GMT
content-encoding
gzip
via
1.1 dd09b3b5f5b8dc626e1ba6804a73af40.cloudfront.net (CloudFront), 1.1 22b9ddafebf39d72780d68dad970d218.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
b2ca65a3-2aa2-4ba7-92aa-70a31abb813c
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GkEebjoEEGhw=
content-length
4852
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57229-1f25da6f1ebd293c61170b87;Parent=4b7891587650106f;Sampled=0;lineage=03d16b22:0|03f65052:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801244f231989-FRA
x-amz-cf-id
EWNLoXt55W7Wn5eBkUTiWMq7NZNGej6vF4ZbT-A-6oVdvh4xpGiM8g==
tags
phnx.dougallmd.com/v2/content/
465 B
1000 B
XHR
General
Full URL
https://phnx.dougallmd.com/v2/content/tags
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9439a9b76e15e3663864e7fe93b4a4b180afb817bafeed2977815823ca62903e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:49 GMT
content-encoding
gzip
via
1.1 22ec86e3f4ec676e17ef8eea76eefba2.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
411f1268-7515-4e48-aa1c-127e72ae580a
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GjGKzDoEET0w=
content-length
272
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57229-0101eb904ac627ab73b1caa5;Parent=75ff0e5e647f6683;Sampled=0;lineage=03d16b22:0|2f9f9b06:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801243f181989-FRA
x-amz-cf-id
rNggRNU6DuvnJJWNZy2HKRVUdC8NpstLqpZWeqBJD1d7tQKcqRgUEw==
ns-prompt
phnx.dougallmd.com/v2/gpt/
295 B
961 B
XHR
General
Full URL
https://phnx.dougallmd.com/v2/gpt/ns-prompt
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
bc208c2a285a5bef21468dd6b71efb0d7c81d0aa741e9c6eb433ba8fc9e40718
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:50 GMT
content-encoding
gzip
via
1.1 c0c6d7afa25d841027d75444425d2010.cloudfront.net (CloudFront), 1.1 cb1bcb02f5d0667fafd0890701965f18.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
d4160359-0528-4e7b-bc5a-e1d4e1b98741
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GmGX2DoEEoRQ=
content-length
230
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57229-2e6477081a0530f36abe8a10;Parent=150d1b235cca8bee;Sampled=0;lineage=03d16b22:0|9d83ff52:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801250f8d1989-FRA
x-amz-cf-id
sS6NH5DADrlKyMXZSh3VQeqQKVJzAgNGr_8kpWcn3J7ZbGJBF3LqwA==
piwik.php
a.dougallmd.com/
0
200 B
Ping
General
Full URL
https://a.dougallmd.com/piwik.php
Requested by
Host: a.dougallmd.com
URL: https://a.dougallmd.com/piwik.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/8.1.29
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=utf-8

Response headers

date
Wed, 21 Aug 2024 04:50:49 GMT
content-encoding
none
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
DYNAMIC
server
cloudflare
x-bot-score
89
x-powered-by
PHP/8.1.29
access-control-allow-origin
https://dougallmd.com
access-control-allow-credentials
true
cf-ray
8b680123f8521957-FRA
alt-svc
h3=":443"; ma=86400
river
phnx.dougallmd.com/v2/fb/search/article/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/river
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b6801239eaf1989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:49 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 a2eae5bb517678c9d6b43a2731b4462e.cloudfront.net (CloudFront), 1.1 22b9ddafebf39d72780d68dad970d218.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GjH4WDoEEKoA=
x-amz-cf-id
c0uChJ8maV456RH2Tv-9vCrALcRzp433sffguHB922D2GGVuBM1QdA==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
01e0548d-4dda-4ceb-b7f0-1b41b826c8e5
x-cache
Miss from cloudfront
x-content-type-options
nosniff
tags
phnx.dougallmd.com/v2/content/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/content/tags
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b6801239eb01989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:49 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 7b20af4202adb6ef25a7920ed74908dc.cloudfront.net (CloudFront), 1.1 8e83c42d247a31c5b365c08a0352d8f8.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GjEvVDoEEXCQ=
x-amz-cf-id
Jj-AGFtOwyS8Lwv7Sa5TOCwpAs80R-9AUzV1IR9N_tE1F5IgBk0UUQ==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
69b493b8-9677-460a-a134-6f5c8c1e1bfc
x-cache
Miss from cloudfront
x-content-type-options
nosniff
ns-prompt
phnx.dougallmd.com/v2/gpt/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/gpt/ns-prompt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
8b680123aeb31989-FRA
content-length
0
content-type
application/json
date
Wed, 21 Aug 2024 04:50:49 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 409b27093eb36cec367cdee5f3ecf8b2.cloudfront.net (CloudFront), 1.1 cb1bcb02f5d0667fafd0890701965f18.cloudfront.net (CloudFront)
x-amz-apigw-id
c17GkGuEDoEEODQ=
x-amz-cf-id
BzS13UUfP07yms2Hi4L15KSiFWnP00EVqMCSDp0ydcGgDkW7l1iV5w==
x-amz-cf-pop
FRA56-P6 FRA56-C2
x-amzn-requestid
bbd06a7a-d7ac-45f7-b5c6-45a065950768
x-cache
Miss from cloudfront
x-content-type-options
nosniff
river
phnx.dougallmd.com/v2/fb/search/article/
32 KB
9 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/river
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a5f27cf023be94a4f404d01163af65d41104776f2285156ac58177bce99451b7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 21 Aug 2024 04:50:51 GMT
content-encoding
gzip
via
1.1 e1f996a9009532eeea33edfd32ef3240.cloudfront.net (CloudFront), 1.1 0d4b487d54766de7560aa02de852bbf8.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
52c00152-291b-441d-b239-67c881683f11
x-cache
Miss from cloudfront
x-amz-apigw-id
c17GkGrTDoEEloQ=
content-length
8841
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-66c57229-32cc5674407866e52cff5d2f;Parent=7bab357f7a5a0922;Sampled=0;lineage=03d16b22:0|03f65052:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
8b6801245f2c1989-FRA
x-amz-cf-id
ECW-GDuo9HE2SwHs8bkk2ipIRletoXStTYwA7ewte3VjCWh0xPhAMQ==
Salani_Ritu_0822_V@2x.png
peerview.com/files/public/media/images/faculty/photo/
15 KB
16 KB
Image
General
Full URL
https://peerview.com/files/public/media/images/faculty/photo/Salani_Ritu_0822_V@2x.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:1449 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8547c4d4c7ab774e7702f48677787d6d3be1a664dae075831defd7e1a9c32195
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:50 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
via
1.1 a7089858ca46e4593c8301dd0b1a2cd2.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA60-P10
x-cache
Miss from cloudfront
content-length
15837
last-modified
Mon, 29 Aug 2022 19:36:36 GMT
server
cloudflare
etag
"3ddd-5e76661c37f7d"
vary
Accept-Encoding
content-type
image/png
cache-control
public, max-age=1209600
accept-ranges
bytes
cf-ray
8b6801271fd09746-FRA
x-amz-cf-id
OT_PZMRuJunXYs6mklKN5OYUgV9YjOCW-kyVb5z-k-Oaj13nNveOIA==
expires
Wed, 04 Sep 2024 04:50:50 GMT
piwik.php
a.dougallmd.com/
0
200 B
Ping
General
Full URL
https://a.dougallmd.com/piwik.php
Requested by
Host: a.dougallmd.com
URL: https://a.dougallmd.com/piwik.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/8.1.29
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=utf-8

Response headers

date
Wed, 21 Aug 2024 04:50:50 GMT
content-encoding
none
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
DYNAMIC
server
cloudflare
x-bot-score
89
x-powered-by
PHP/8.1.29
access-control-allow-origin
https://dougallmd.com
access-control-allow-credentials
true
cf-ray
8b680128fc801957-FRA
alt-svc
h3=":443"; ma=86400
piwik.php
a.dougallmd.com/
0
200 B
Ping
General
Full URL
https://a.dougallmd.com/piwik.php
Requested by
Host: a.dougallmd.com
URL: https://a.dougallmd.com/piwik.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/8.1.29
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=utf-8

Response headers

date
Wed, 21 Aug 2024 04:50:50 GMT
content-encoding
none
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
DYNAMIC
server
cloudflare
x-bot-score
89
x-powered-by
PHP/8.1.29
access-control-allow-origin
https://dougallmd.com
access-control-allow-credentials
true
cf-ray
8b6801294cb41957-FRA
alt-svc
h3=":443"; ma=86400
dgan
api.phnxml.io/v2/content/
Redirect Chain
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=100043417/emailid=15250419/personid=100043417/channel=website/size=520x150/geography=be/prof=12/spec=159/viewid=10...
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=cH1bTRJ5hCH7_MmPZpFi9KbtaPvqX-B3FREYkYXd7kRDqEEKIdCzbg%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fpropert...
2 KB
1 KB
XHR
General
Full URL
https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=cH1bTRJ5hCH7_MmPZpFi9KbtaPvqX-B3FREYkYXd7kRDqEEKIdCzbg%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D11236%2Fpid%3D21236%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215851600&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36
Protocol
H2
Server
2600:9000:211e:8600:f:e0ca:fec0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
4286bd7dc02bc52dd23662000f532b38f86f01b417cfa8baeea8ebb0af927ad3

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:52 GMT
content-encoding
gzip
via
1.1 ab68583a58d574d6a9e5fca1fb1e6316.cloudfront.net (CloudFront), 1.1 6c7a5d26be7fb35284e54d321f16b6f6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-P6, FRA56-C2
x-amzn-requestid
96a2c9fe-2e43-41f5-a06e-8bde168f659f
x-amzn-trace-id
Root=1-66c5722b-3cd974666ce89f1f2651864b;Parent=2aaa05fc729b5cf3;Sampled=0;lineage=096f8394:0
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
x-amz-apigw-id
c17G6FU5joEEt3g=
content-length
752
x-amz-cf-id
dqzHe0EBfBBkoIap9FlIqfwP9t97DDpl77XuZYr3ApocPR--9DuUXg==

Redirect headers

date
Wed, 21 Aug 2024 04:50:51 GMT
via
1.1 a5010656f4f762c0fdffac3448496b86.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P7
x-cache
Miss from cloudfront
location
https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=cH1bTRJ5hCH7_MmPZpFi9KbtaPvqX-B3FREYkYXd7kRDqEEKIdCzbg%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D100043417%2Femailid%3D15250419%2Fpersonid%3D100043417%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D159%2Fviewid%3D1000434175301724215847919%2Frandom%3D11236%2Fpid%3D21236%2FCampaignID%3D1%2FinteractionId%3Dc2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1724215851600&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(X11%3B%20Linux%20x86_64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F127.0.0.0%20Safari%2F537.36
access-control-allow-origin
*
access-control-expose-headers
*
cf-ray
8b6801304f8d1989-FRA
alt-svc
h3=":443"; ma=86400
content-length
0
x-amz-cf-id
cH1bTRJ5hCH7_MmPZpFi9KbtaPvqX-B3FREYkYXd7kRDqEEKIdCzbg==
collect
t.clarity.ms/
0
277 B
XHR
General
Full URL
https://t.clarity.ms/collect
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMDA0MzQxNy01ZjZmMzQ2MS0xNzI0MTc2ODk1NjU0Iiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtYTQzMjlmNTYtYWUwNC00ODhlLTg4NGMtY2IyNThiZGE3ZGE1IiwicGFydHlJZCI6MTAwMDQzNDE3LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MjQyMTU4NDUsImV4cCI6MTcyNjgwNzg0NX0.PFZsT7BegqkMtLHKQh2X7I8QHfHbwJo5hNu662qnblE&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
20.114.189.70 Boydton, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
application/x-clarity-gzip
Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://dougallmd.com
Date
Wed, 21 Aug 2024 04:50:52 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Vary
Origin
Request-Context
appId=cid-v1:593e4080-f032-4d00-a652-e17f01252a9d
abstract.png
c-phnx.dougallmd.com/assets/newsletter/dg/journal_logos/
3 KB
3 KB
Image
General
Full URL
https://c-phnx.dougallmd.com/assets/newsletter/dg/journal_logos/abstract.png
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
18bcf445a0eba6a6027afa0e3a41eda1b2e925bc1d2924eb229ce71199ea6c14
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Wed, 21 Aug 2024 04:50:52 GMT
x-amz-version-id
null
via
1.1 f0ff3515536254a60a04240b4114639c.cloudfront.net (CloudFront)
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P10
age
6
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
2691
last-modified
Mon, 14 Feb 2022 17:08:21 GMT
server
cloudflare
etag
"31e5fe94843620f928c01872e3807938"
vary
Accept-Encoding, Origin
content-type
image/png
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
8b680134adfa1957-FRA
x-amz-cf-id
x6UPqNo8uNKfupzJ1TulV4SZVJhyKvGXEkZgse5TLctrtWcclnTi9Q==
expires
Wed, 21 Aug 2024 08:50:52 GMT
150209150-2-ad2.png
c.peerview.com/ads/
116 KB
116 KB
Image
General
Full URL
https://c.peerview.com/ads/150209150-2-ad2.png
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2761:8200:14:47ee:23c0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
af4b08de92d7a96b263f63054e00ece33a4a7f053a995f5d58ed01fb7c29ae43

Request headers

Referer
https://dougallmd.com/
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Mon, 29 Jul 2024 06:19:58 GMT
x-amz-version-id
ClI0WbW6KmhokrS.gkb5WN5hkZbTv.uK
via
1.1 d60e84ebd0183f97f50eb1677fb4b7be.cloudfront.net (CloudFront)
last-modified
Sun, 07 Apr 2024 20:42:48 GMT
server
AmazonS3
x-amz-cf-pop
FRA60-P8
age
1981855
etag
"47f451c7b6eb21b119e2f69fe2464f6e"
x-amz-server-side-encryption
AES256
vary
Origin
x-cache
Hit from cloudfront
content-type
image/png
accept-ranges
bytes
content-length
118708
x-amz-cf-id
q05WwCCSHCU3ubPrAKfoE9IjjU0EqvD6MKGUfszngY-g3760gu8nkQ==
UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1pL7SUc.woff2
fonts.gstatic.com/s/inter/v18/
19 KB
19 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v18/UcC73FwrK3iLTeHuS_nVMrMxCp50SjIa1pL7SUc.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Inter:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e6025d5b92700a6958e774cc8d88927591131bfbbf4bb2d9e39279df2b3a2dac
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://dougallmd.com
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/127.0.0.0 Safari/537.36

Response headers

date
Tue, 20 Aug 2024 14:27:52 GMT
x-content-type-options
nosniff
age
51780
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
19072
x-xss-protection
0
last-modified
Mon, 29 Jul 2024 22:50:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 20 Aug 2025 14:27:52 GMT
collect
t.clarity.ms/
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
rvid.imperium.com
URL
https://rvid.imperium.com/dedupe
Domain
rvid.imperium.com
URL
https://rvid.imperium.com/dedupe
Domain
t.clarity.ms
URL
https://t.clarity.ms/collect

Verdicts & Comments Add Verdict or Comment

172 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| NREUM object| newrelic function| __nr_require function| clarity object| SASIA boolean| SASIA_VIEWTRACKER_DEBUG boolean| SASIA_VIEWTRACKER_ALLOW_BLURRED object| webpackChunkcra_template function| clearImmediate function| setImmediate function| _ object| di function| Inputmask function| Formio object| FormioUtils boolean| __userflowStatePatched object| userflow object| USERFLOWJS_QUEUE object| _paq object| webpackChunk:NRBA-1.264.0.PROD object| Piwik object| Matomo object| AnalyticsTracker function| piwik_log object| NEML object| RVIDPrivacy string| _RVIDCaptureString object| _extraDataPoints string| _version object| captureObject string| __xe1913148__ object| PluginDetect string| userAgent boolean| isLinux boolean| isChrome number| counter object| body1 number| jsver object| BrowserDetect string| propertyString1 object| RVIDFlash string| hasRIF function| sha256 string| imperiumOriginalCookie function| sendLogMessageAsync function| createRVIDXMLHttpRequest function| setHoPoDetection function| tochar function| rvidPing function| setRVIDDataReadyAndSubmitForm function| callRVIDNow function| addValue function| addCapValue function| getOS function| checkIframes function| getSilverlightVersion function| getSilverlightMajorVersion function| detectSilverlight function| detectDirector function| getDirectorVersion function| getWindowsMediaVersion function| detectWindowsMedia function| isFlip4MacInstalled function| Flip4MacVersion function| getFlashInfo function| canDetectNavigatorPlugins function| detectPlugin function| getAllPlugins function| createScriptTag function| getJavascriptVersion function| BrowserInfo function| Get_Cookie function| Set_Cookie function| GetFontSize function| getTimeZoneDiff function| getJavaScriptBuild function| getBrowserBuild function| getNetMeetingBuild function| getServicePack function| getUserLanguage function| getSystemLanguage function| detectGecko function| getGeckoBuildDateToInt function| getConnectionType function| supportsDHTML function| supportsXMLHttpRequest function| supportsXML function| getAolVersion function| isEmailCrawler function| canUploadFile function| persistentCookies function| sessionCookies function| ExpireCookie_ function| addToCapture function| getBrowserTime function| getBrowserTimeMS function| getJavaEnabled function| getDataPoints function| rvidFreezeSetProp function| AddScriptTag function| checkTime function| checkTimeTime function| getDateTime function| createDiv function| createSol function| writeRIF function| setRIF1 function| setRIF2 function| getRIF1 function| readRIF function| rifStatusCheck function| createField function| createRVIDField function| createOutputFields function| getScore function| IsPageTranslated function| executeService function| isPropStringValid function| LogWarningForAnyMissingRequestPars function| LogWarningForMissingRequestPar function| getFunctionHash function| ImperiumXhrPost function| ImperiumGetValue function| isSSLv3MigratedClient function| getCNprintLegacyHash function| getCNprintLegacy function| getCNprintHash function| getWebGLRenderer function| getWebGLDataHash function| Get_CookieRIF3 function| Set_CookieRIF3 function| Expire_CookieRIF3 function| setRIF3 function| getRIF3 function| isMobile function| isMobile1 function| inIframe function| featDetectBrowser function| _pluginContains function| checkForAutomatedBrowserProps function| notificationPermissions function| isNotificationPermissionsOverridden function| keyboardLayoutMapSize function| mediaDevicesConstraintsCount function| _supportsBluetooth function| storageManagerDetails function| _userAgentClientHints function| _accelDetect function| _gyroDetect function| getAudioSampleRate function| mediaDeviceGroups function| _detectPrivacyMode function| getAllMimeTypes function| rvidDevToolsOpen object| relevantID object| jstz number| RVIDTrack object| C object| ZZZ object| MobileOSArray object| MobileType object| isThisMobile object| browserobject number| pluginsArrayCounter number| namesCounter object| ma number| RVIDReady function| RVIDResponseComplete function| getScoreAdditional object| start1 object| start2 object| start4

12 Cookies

Domain/Path Name / Value
dougallmd.com/article Name: RVIDExtId
Value: 087C2DF2-ED31-4B3F-838E-7CCA1C9D971A
.dougallgpt.com/ Name: __cf_bm
Value: w7VarIdc2pp8Aploqdx0Z4qKXt016s90xG5rKp91a9E-1724215841-1.0.1.1-ukFnNdPfUc7PjbTvRm.VMX1.qd.eQvj6L3Ljn0nT4r5ULFHtW6g.p0wxyPzfz2tnd3MzqD3lsfS1AT5OKEAt3w
dougallgpt.com/ Name: interactionId
Value: GRVv9OJ534r3IeKVxUxnIN4uSR2D7Vpn5WyNZgRVy1OnDC1g3FOnKw==
dougallgpt.com/ Name: _pk_id.150.0e10
Value: 0ac7c738e4e0c643.1724215845.
dougallgpt.com/ Name: _pk_ses.150.0e10
Value: 1
dougallgpt.com/ Name: _pk_id.146.0e10
Value: b5e55d5f1ed2e6fe.1724215845.
.dougallmd.com/ Name: __cf_bm
Value: NDkZXMBjh436vN8XkvvXjygMVrR6WCW7Eh91yQeRNmc-1724215845-1.0.1.1-YtyineOikw86Q6S8M.b0XI6jiefLLf0yF4K7k9s26R_fGHkW_fN57s2pW6hVsc2plj9AGXeQYxIErGCp4SVAqA
dougallmd.com/ Name: interactionId
Value: c2vBhtt9BPP8JZMm6RQ9Hd38osklX61_8F4DxdN3saO3rNgQSGWamw==
dougallmd.com/ Name: _pk_ref.147.5ce0
Value: %5B%22%22%2C%22%22%2C1724215849%2C%22https%3A%2F%2Fdougallgpt.com%2F%22%5D
dougallmd.com/ Name: _pk_id.147.5ce0
Value: bf02d0a8657d9895.1724215849.
dougallmd.com/ Name: _pk_ses.147.5ce0
Value: 1
.peerview.com/ Name: __cf_bm
Value: fnUUm4vAYvQ5oOAMtW5MYMBl8MAEYiJiGmewkoT9r98-1724215850-1.0.1.1-_6Dug.3f2Jjuf2kiEgmGVh00gr.e1zW0knJ4bQlGCxezFtw1eV0LLKjlrZaj1y8ICiaRJR.HPotRMY.L8Tf4Xg

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a.dougallgpt.com
a.dougallmd.com
api.neml.io
api.phnxml.io
bam.eu01.nr-data.net
c-neml.dougallgpt.com
c-neml.dougallmd.com
c-phnx.dougallgpt.com
c-phnx.dougallmd.com
c.peerview.com
content.aimatch.com
dougallgpt.com
dougallmd.com
fonts.googleapis.com
fonts.gstatic.com
js-agent.newrelic.com
p-dgan.dougallmd.com
peerview.com
phnx.dougallgpt.com
phnx.dougallmd.com
rvid.imperium.com
t.clarity.ms
www.clarity.ms
rvid.imperium.com
t.clarity.ms
185.221.85.3
185.221.87.23
2.17.100.131
20.114.189.70
2600:9000:211e:8600:f:e0ca:fec0:93a1
2600:9000:211e:d600:f:e0ca:fec0:93a1
2600:9000:2761:8200:14:47ee:23c0:93a1
2602:816:5001::39
2606:4700::6812:12f0
2606:4700::6812:13f0
2606:4700::6812:1449
2606:4700::6812:aac
2606:4700::6812:bac
2620:1ec:bdf::67
2a00:1450:4001:80b::2003
2a00:1450:4001:82a::200a
3.161.82.20
34.206.159.125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